Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells.
In Vivo
; 36(5): 2105-2115, 2022.
Article
in En
| MEDLINE
| ID: mdl-36099094
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Triple Negative Breast Neoplasms
/
Gliotoxin
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
In Vivo
Year:
2022
Document type:
Article